PhaseBio Pharmaceuticals, Inc.
PHAS · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$0 | -$99 | -$39 | -$24 |
| Dep. & Amort. | $2 | $1 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $2 | $1 | $0 |
| Change in WC | $29 | -$4 | -$2 | $2 |
| Other Non-Cash | -$81 | $40 | $1 | $4 |
| Operating Cash Flow | -$47 | -$60 | -$40 | -$17 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$1 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$3 | -$1 | -$1 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $60 | $3 | $46 | $43 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $64 | $15 | $54 | $65 |
| Financing Cash Flow | $64 | $15 | $54 | $65 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $14 | -$46 | $13 | $48 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $28 | $74 | $61 | $13 |
| End Cash | $42 | $28 | $74 | $61 |
| Free Cash Flow | -$50 | -$61 | -$41 | -$17 |